EUVIMEDEUVIMED entdecken
Validierungsstudie

PREG-ADR: development and validation of a predictive tool for adverse drug reactions in hospitalized pregnant women

Priscilla Karilline do Vale Bezerra, Larissa Cândido Gomes da Silva, Hilris Rocha E Silva, Sabrina Maria Portela Carneiro, Sheylla Jennifer de Alencar Arrais Baia, Antonio Gouveia Oliveira, Rand Randall Martins

Expert Review of Clinical Pharmacology · 2025

DOI: 10.1080/17512433.2025.2590686 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Expert Review of Clinical Pharmacology, 2025. Verfasst von Priscilla Karilline do Vale Bezerra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Pharmaceutical Services and Policies, Health sciencescenter, Federal University of Rio Grande do Norte, Natal, Brazil. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Pregnancy Complications. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Adverse drug reactions (ADRs) in hospitalized pregnant women remain under-recognized, and no validated risk prediction tools exist. We developed and validated a tool to estimate individual ADR risk in this population. RESEARCH DESIGN AND METHODS: A nested case-control study was conducted within a prospective cohort of high-risk pregnant women admitted to a Brazilian hospital from September 2021 to July 2023. Patients receiving at least one medication during a hospital stay > 24 hours were eligible. ADRs were classified as 'probable' or 'definite' using the Naranjo algorithm. Multivariate logistic regression identified independent predictors. Discriminative performance was assessed by the area under the ROC curve (AUC); calibration was evaluated using the Hosmer-Lemeshow test and Brier score. RESULTS: Among 330 women (110 cases and 220 controls), eight independent predictors of ADRs were identified: gestational hypertensive syndrome, drug allergy, aPTT ≥27.9 seconds, hospitalization ≥7 days, blurred vision, sedation, nausea, and polypharmacy (≥5 drugs). The final score (0-100) showed good performance at a cutoff ≥34 (AUC: 0.77; 95% CI: 0.71-0.82) and satisfactory calibration (p = 0.528; Brier = 0.27). CONCLUSION: PREG-ADR demonstrated strong predictive performance and may support identification of high-risk pregnant women to improve pharmacotherapy safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Related Side Effects and Adverse ReactionsPregnancy ComplicationsHumansFemalePregnancyAdultProspective StudiesHospitalizationCase-Control StudiesBrazilRisk AssessmentYoung AdultLogistic ModelsRisk FactorsPolypharmacyAlgorithmsROC Curve

Stichwörter der Autor:innen

Adverse drug reactionsclinical pharmacyhigh-risk pregnancypharmacovigilancewoman’s health

Autor:innen und Institutionen

  • Graduate Program in Pharmaceutical Services and Policies, Health sciencescenter, Federal University of Rio Grande do Norte, Natal, Brazil.
  • Department of Pharmacy, Health Sciences Center, Federal University of Rio Grande do Norte, Natal, Brazil.
  • Department of Pharmacy, Health Sciences Center, Federal University of Piauí, Teresina, Brazil.
  • Dona Evangelina Rosa Maternity, State Health Department of Piauí, Teresina, Brazil.
  • Graduate Program of Pharmaceutical Sciences, Health Sciences Center, Federal University of Rio Grande do Norte, Natal, Brazil.

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

do Vale Bezerra, P. K., da Silva, L. C. G., Rocha E Silva, H., Portela Carneiro, S. M., de Alencar Arrais Baia, S. J., Gouveia Oliveira, A., & Martins, R. R. (2025). PREG-ADR: development and validation of a predictive tool for adverse drug reactions in hospitalized pregnant women. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2025.2590686

Vancouver

do Vale Bezerra PK, da Silva LCG, Rocha E Silva H, Portela Carneiro SM, de Alencar Arrais Baia SJ, Gouveia Oliveira A, et al. PREG-ADR: development and validation of a predictive tool for adverse drug reactions in hospitalized pregnant women. Expert Review of Clinical Pharmacology. 2025. doi:10.1080/17512433.2025.2590686

BibTeX
@article{doValeBezerra2025,
  author = {do Vale Bezerra, Priscilla Karilline and da Silva, Larissa Cândido Gomes and Rocha E Silva, Hilris and Portela Carneiro, Sabrina Maria and de Alencar Arrais Baia, Sheylla Jennifer and Gouveia Oliveira, Antonio and Martins, Rand Randall},
  title = {PREG-ADR: development and validation of a predictive tool for adverse drug reactions in hospitalized pregnant women},
  journal = {Expert Review of Clinical Pharmacology},
  year = {2025},
  doi = {10.1080/17512433.2025.2590686}
}
Kostenlos starten →